Sedana Medical receives market approval in Saudi Arabia and signs distribution agreements for the Middle East
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the medical device AnaConDa has received market approval in Saudi Arabia and that the company has signed distribution agreements for sales in the Middle East with Techno Orbits in Saudi Arabia, CityPharmacy in the United Arab Emirates and IBN SINA Pharmacy in Oman. Sales are expected to start shortly in Saudi Arabia. In the other countries, parallel registration processes have started, and sales are expected to commence within a few months. Sedana Medical estimates that the annual market potential in the Middle East is just